Plans and forecasts

The company "Immunotechnology" created by Sberbank will not produce coronavirus vaccine, said the head of the state bank German Gref during an online briefing. The company will support such production, acting as a design office in the framework of joint work with the Ministry of Health. Immunotechnologies was registered on May 15, and wholesale of pharmaceutical products is declared the main activity.